Pay in 4 interest-free payments of $6.57 Learn more
Ships within 48 hours · Estimated delivery Aug 22 - Aug 27
The duration depends on the patients response and the progression of their condition
Tirzepatide is a dual glucose-dependent insulinotropic polypeptide (GIP) and glucagon-like peptide-1 (GLP-1) receptor agonist licensed in the UK for the treatment of type 2 diabetes mellitus (Mounjaro) and, more recently, for weight management in adults with obesity or overweight with weight-related comorbidities (Zepbound)
Most often, heart palpitations occur without any obvious cause
Dosing Errors : There is a risk of patients inadvertently administering more than the prescribed dose
P = 0.01)[45]
US$ 24.62
US$ 22.77
US$ 26.03
US$ 21.32
US$ 20.46
US$ 21.87
US$ 27.85
US$ 22.71
US$ 21.08
US$ 29.05
US$ 26.18
